New Key Statistics Module, Z-Score and F-Score
NAS:VYNE Key Ratios
Market Cap $ M | 38.21 |
Enterprise Value $ M | -56.10 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 0.43 |
Price/Sales | 24.41 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -7.28 |
Beneish M-Score | -3.79 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 60.20 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 1.92 |
EV-to-EBITDA | 1.92 |
PEG | -- |
Shares Outstanding M | 14.10 |
Net Margin (%) | -6,710.38 |
Operating Margin % | -6,900.71 |
Pre-tax Margin (%) | -6,573.82 |
Quick Ratio | 12.73 |
Current Ratio | 12.73 |
ROA % (ttm) | -65.28 |
ROE % (ttm) | -81.22 |
ROIC % (ttm) | -823.13 |
Dividend Yield % | -- |
Altman Z-Score | -7.28 |
VYNE Number of Guru Trades
VYNE Volume of Guru Trades
Gurus Latest Trades with NAS:VYNE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:VYNE is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
VYNE Therapeutics Inc Insider Transactions
No Available Data
News about NAS:VYNE
Total 0- 1